A fusion protein derived from plants holds promising potential as a new oral therapy for type 2 diabetes.
about
Fusion Proteins for Half-Life Extension of Biologics as a Strategy to Make BiobettersOral Delivery of Protein Drugs Bioencapsulated in Plant CellsMelatonin protects against blood-brain barrier damage by inhibiting the TLR4/ NF-κB signaling pathway after LPS treatment in neonatal rats.Intranasal basic fibroblast growth factor attenuates endoplasmic reticulum stress and brain injury in neonatal hypoxic-ischaemic injuryNerve growth factor-induced Akt/mTOR activation protects the ischemic heart via restoring autophagic flux and attenuating ubiquitinated protein accumulation.Inhibiting endoplasmic reticulum stress by lithium chloride contributes to the integrity of blood-spinal cord barrier and functional recovery after spinal cord injury.Low-cost oral delivery of protein drugs bioencapsulated in plant cells.Expression and functional evaluation of biopharmaceuticals made in plant chloroplasts.Plant-based oral delivery of β-glucocerebrosidase as an enzyme replacement therapy for Gaucher's disease.Inhibition of endoplasmic reticulum stress is involved in the neuroprotective effect of aFGF in neonatal hypoxic-ischaemic brain injury.Dl-3-n-butylphthalide attenuates acute inflammatory activation in rats with spinal cord injury by inhibiting microglial TLR4/NF-κB signalling.Characterization and Oral Delivery of Proinsulin-Transferrin Fusion Protein Expressed Using ExpressTec.Companion Protease Inhibitors for the In Situ Protection of Recombinant Proteins in Plants.
P2860
Q26801319-94618B74-DDCA-4B62-AE10-FDEB5E9CBA62Q28079063-6F8D1728-E32F-41F5-92FD-111EE2CF6AF4Q33761852-5B01F7BA-D1EA-4405-90C2-A92FF483A102Q37685204-DBF10253-D18A-4D4C-84DE-1F47CCBB75EFQ37706365-7CDA8593-F2DB-4871-96FD-C5A8429C9E94Q37732967-CCC266CA-70B9-4637-9338-8AA232EB75D1Q38662352-CD59875E-1713-4AC9-AD53-613B1C01B212Q39147640-B60E023F-10C7-4913-A17D-4FE80F05A763Q41365905-230B4F76-F922-46EC-A45A-AA8497346337Q42365253-95451777-FFBC-4DA2-9793-C3E2FE560F95Q45732351-2DB5F6AB-4B1C-402A-A70C-D13B0806DF68Q48159203-0AB324A3-F791-462C-A8FA-FA9D6AA10005Q51626860-187DC663-E240-42B9-B1B1-FBC85DB9B2E0
P2860
A fusion protein derived from plants holds promising potential as a new oral therapy for type 2 diabetes.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
A fusion protein derived from ...... l therapy for type 2 diabetes.
@en
A fusion protein derived from ...... l therapy for type 2 diabetes.
@nl
type
label
A fusion protein derived from ...... l therapy for type 2 diabetes.
@en
A fusion protein derived from ...... l therapy for type 2 diabetes.
@nl
prefLabel
A fusion protein derived from ...... l therapy for type 2 diabetes.
@en
A fusion protein derived from ...... l therapy for type 2 diabetes.
@nl
P2093
P2860
P356
P1476
A fusion protein derived from ...... l therapy for type 2 diabetes.
@en
P2093
Anthony M Jevnikar
Arthur Lau
Jeehye Choi
Rennian Wang
Shengwu Ma
Zhi-Chao Feng
P2860
P304
P356
10.1111/PBI.12149
P577
2013-12-30T00:00:00Z